We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$1.67B
AUM Growth
-$505M
Cap. Flow
-$520M
Cap. Flow %
-31.03%
Top 10 Hldgs %
29.21%
Holding
171
New
21
Increased
23
Reduced
68
Closed
55

Top Sells

Rank Stock Value
1
CHRD icon
Chord Energy
CHRD
+$73.2M
2
TFX icon
Teleflex
TFX
+$52.2M
3
AKAM icon
Akamai
AKAM
+$46.6M
4
RNG icon
RingCentral
RNG
+$30.2M
5
HAE icon
Haemonetics
HAE
+$28.8M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Healthcare 19.57%
3 Industrials 14.44%
4 Consumer Discretionary 10.33%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBS icon
51
HubSpot
HUBS
$13B
$11.9M 0.71%
65,146
+38,928
+148% +$8.14M
SSTK icon
52
Shutterstock
SSTK
$221M
$11.5M 0.69%
822,696
-36,941
-4% -$582K
CAL icon
53
Caleres
CAL
$419M
$11.2M 0.67%
902,633
-201,380
-18% -$2.61M
IART icon
54
Integra LifeSciences
IART
$1.31B
$10.4M 0.62%
579,036
-432,279
-43% -$6.05M
HELE icon
55
Helen of Troy
HELE
$667M
$10.4M 0.62%
357,451
-292,008
-45% -$6.91M
MKTX icon
56
MarketAxess Holdings
MKTX
$5.73B
$10.3M 0.61%
+90,441
New +$12.9M
MTN icon
57
Vail Resorts
MTN
$5.06B
$10.2M 0.61%
75,225
-35,318
-32% -$4.6M
FLGT icon
58
Fulgent Genetics
FLGT
$540M
$10.2M 0.61%
498,287
-112,031
-18% -$1.9M
MATV icon
59
Mativ Holdings
MATV
$669M
$10.2M 0.61%
1,348,326
-585,103
-30% -$5.04M
FLO icon
60
Flowers Foods
FLO
$1.51B
$10M 0.6%
1,271,875
+121,536
+11% +$973K
SSNC icon
61
SS&C Technologies
SSNC
$19.6B
$9.88M 0.59%
+159,291
New +$10.8M
DNOW icon
62
DNOW Inc
DNOW
$2.88B
$9.81M 0.59%
+756,582
New +$9.82M
ACH
63
Accendra Health
ACH
$93.1M
$9.62M 0.57%
2,812,474
-556,501
-17% -$1.73M
M icon
64
Macy's
M
$5.79B
$9.36M 0.56%
397,367
-653,956
-62% -$13.7M
FUN icon
65
Cedar Fair
FUN
$1.66B
$9.19M 0.55%
431,403
-994,764
-70% -$20.3M
ROCK icon
66
Gibraltar Industries
ROCK
$1.34B
$9.17M 0.55%
203,383
+20,311
+11% +$796K
SPT icon
67
Sprout Social
SPT
$696M
$8.19M 0.49%
1,085,404
-72,049
-6% -$469K
BBY icon
68
Best Buy
BBY
$17.4B
$7.91M 0.47%
+104,275
New +$6.93M
DMC
69
Del Monte Corp
DMC
$1.5B
$7.87M 0.47%
281,867
+109,625
+64% +$3.85M
EPC icon
70
Edgewell Personal Care
EPC
$1.34B
$7.16M 0.43%
266,683
-228,065
-46% -$4.87M
GOOS
71
Canada Goose Holdings
GOOS
$805M
$7.11M 0.42%
747,128
-109,125
-13% -$1.15M
LOVE
72
LoveSac
LOVE
$234M
$6.9M 0.41%
413,318
-53,430
-11% -$845K
OGG
73
Osisko Gold Group
OGG
$939M
$6.85M 0.41%
2,785,633
-778,153
-22% -$2.31M
OTIS icon
74
Otis Worldwide
OTIS
$27.3B
$6.63M 0.4%
92,561
+28,509
+45% +$2.13M
CLW icon
75
Clearwater Paper
CLW
$336M
$6.59M 0.39%
420,419
+116,269
+38% +$1.75M

Similar funds

Invenomic Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Invenomic Capital Management withdrew a net $520M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.

  • Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
  • Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
  • Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
  • Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
  • Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
  • Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
  • Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.